Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents.
Clinical trial NCT05213065 · UNKNOWN
Trial details
- NCT number
- NCT05213065
- Sponsor
- Pablo Ingelmo
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-05
- Primary completion
- 2024-02-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.